Robert Pelley

1.9k total citations
54 papers, 1.5k citations indexed

About

Robert Pelley is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Pelley has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Pelley's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Robert Pelley is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (9 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Robert Pelley collaborates with scholars based in United States, Australia and Chile. Robert Pelley's co-authors include Eren Berber, Allan Siperstein, Mark E. Baker, H J Kung, Hui‐Kuo G. Shu, Ronald P. Pelley, Ronald M. Bukowski, Kenneth S. Warren, Pierre Peters and Joseph Hamburger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Robert Pelley

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Pelley United States 25 716 447 342 318 290 54 1.5k
Yann Touchefeu France 21 829 1.2× 475 1.1× 351 1.0× 157 0.5× 510 1.8× 98 1.6k
Constantine A. Axiotis United States 25 535 0.7× 379 0.8× 339 1.0× 423 1.3× 376 1.3× 65 2.3k
Murli Krishna United States 27 873 1.2× 674 1.5× 307 0.9× 342 1.1× 1.2k 4.3× 99 2.4k
Takehide Asano Japan 27 1.2k 1.6× 748 1.7× 401 1.2× 352 1.1× 1.3k 4.6× 116 2.5k
Masayuki Matsumura Japan 20 610 0.9× 392 0.9× 569 1.7× 224 0.7× 425 1.5× 37 1.6k
Hanspeter Honegger Switzerland 19 820 1.1× 881 2.0× 88 0.3× 102 0.3× 251 0.9× 49 1.7k
Giuseppe Locatelli Italy 15 488 0.7× 303 0.7× 261 0.8× 175 0.6× 391 1.3× 43 1.7k
Randa Alsabeh United States 25 554 0.8× 325 0.7× 465 1.4× 83 0.3× 357 1.2× 40 1.8k
Christoph Kahl Germany 26 1.1k 1.5× 476 1.1× 254 0.7× 234 0.7× 196 0.7× 96 1.9k
David Tai Singapore 21 737 1.0× 306 0.7× 354 1.0× 522 1.6× 292 1.0× 76 1.8k

Countries citing papers authored by Robert Pelley

Since Specialization
Citations

This map shows the geographic impact of Robert Pelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pelley more than expected).

Fields of papers citing papers by Robert Pelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Pelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pelley. The network helps show where Robert Pelley may publish in the future.

Co-authorship network of co-authors of Robert Pelley

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Pelley. A scholar is included among the top collaborators of Robert Pelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Pelley. Robert Pelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estfan, Bassam, Robert Pelley, Smitha Krishnamurthi, et al.. (2019). An Early Look into a Single-Center Experience with Hepatic Artery Chemoinfusion Pumps.
2.
Williams, Anthony, Siddarth Rawal, Zheng Ao, et al.. (2012). Abstract 2372: Capture and molecular characterization of CTC in metastatic breast, prostate, colorectal, and renal cancer. Cancer Research. 72(8_Supplement). 2372–2372. 4 indexed citations
3.
Lazaryan, Aleksandr, et al.. (2011). Predictors of clinical outcomes of resected ampullary adenocarcinoma: A single-institution experience. European Journal of Surgical Oncology. 37(9). 791–797. 22 indexed citations
4.
Campos‐Lobato, Luiz Felipe de, David W. Dietz, Luca Stocchi, et al.. (2010). Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation1. Colorectal Disease. 14(1). 62–67. 27 indexed citations
5.
Almhanna, Khaldoun, Robert Pelley, G. Thomas Budd, Jon Davidson, & Halle C. F. Moore. (2008). Subcutaneous implantable venous access device erosion through the skin in patients treated with anti-vascula endothelial growth factor therapy: a case series. Anti-Cancer Drugs. 19(2). 217–219. 12 indexed citations
6.
Brell, Joanna M., Smitha Krishnamurthi, Milind Javle, et al.. (2008). A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma. Cancer Chemotherapy and Pharmacology. 63(5). 851–857. 11 indexed citations
7.
Kalmadi, Sujith, Timothy M. E. Davis, Afshin Dowlati, et al.. (2006). Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors. Investigational New Drugs. 25(3). 211–216. 17 indexed citations
8.
Barnetson, Ross StC., et al.. (2005). Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans. Letters in Drug Design & Discovery. 2(2). 165–171. 13 indexed citations
9.
Mekhail, Tarek, Thomas E. Hutson, Paul Elson, et al.. (2002). Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies. Cancer. 97(1). 170–178. 9 indexed citations
10.
Pelley, Robert. (2001). Oxaliplatin: A new agent for colorectal cancer. Current Oncology Reports. 3(2). 147–155. 30 indexed citations
11.
Pelley, Robert, Ram Ganapathi, Laura S. Wood, et al.. (2000). A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 46(3). 251–254. 5 indexed citations
12.
Lavery, Ian C., et al.. (2000). TREATMENT OF COLON AND RECTAL CANCER. Surgical Clinics of North America. 80(2). 535–569. 35 indexed citations
13.
Pelley, Robert & Ronald M. Bukowski. (1999). Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors. Current Opinion in Oncology. 11(1). 32–32. 29 indexed citations
14.
Baker, Mark E. & Robert Pelley. (1995). Hepatic metastases: basic principles and implications for radiologists.. Radiology. 197(2). 329–337. 83 indexed citations
15.
Shu, Hui‐Kuo G., L Ravi, Lei Ling, et al.. (1994). Modulation of erbB kinase activity and oncogenic potential by single point mutations in the glycine loop of the catalytic domain.. Molecular and Cellular Biology. 14(10). 6868–6878. 16 indexed citations
16.
Budd, G. Thomas, Valentina De Lorenzi, Ram Ganapathi, et al.. (1994). Amifostine: potential for clinically useful cytoprotection. Supportive Care in Cancer. 2(6). 380–384. 11 indexed citations
17.
Pretlow, T G, S R Wolman, Mark A. Micale, et al.. (1993). Xenografts of Primary Human Prostatic Carcinoma. JNCI Journal of the National Cancer Institute. 85(5). 394–398. 126 indexed citations
18.
Kung, Hsing‐Jien, Robert Pelley, Hui‐Kuo G. Shu, et al.. (1990). Retroviral insertional mutagenesis: the making of a receptor-oncogene.. PubMed. 72. 139–44. 2 indexed citations
19.
Pelley, Robert, C. Moscovici, Stephen H. Hughes, & H J Kung. (1988). Proviral-activated c-erbB is leukemogenic but not sarcomagenic: characterization of a replication-competent retrovirus containing the activated c-erbB. Journal of Virology. 62(5). 1840–1844. 28 indexed citations
20.
Saarinen, Ulla M., Peter F. Coccia, Stanton L. Gerson, Robert Pelley, & Nai‐Kong V. Cheung. (1985). Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.. PubMed. 45(11 Pt 2). 5969–75. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026